Results 211 to 220 of about 309,449 (261)
Some of the next articles are maybe not open access.
Journal of Alzheimer's Disease, 2010
The worldwide costs of dementia are US$315 billion [1]. Monthly costs of Alzheimer’s disease in Spain are 1,426 per month [2]. What is the purpose, value, and usefulness of such statements? The number of Cost of Illness (CoI) studies is steadily increasing.
openaire +3 more sources
The worldwide costs of dementia are US$315 billion [1]. Monthly costs of Alzheimer’s disease in Spain are 1,426 per month [2]. What is the purpose, value, and usefulness of such statements? The number of Cost of Illness (CoI) studies is steadily increasing.
openaire +3 more sources
Journal of Pain & Palliative Care Pharmacotherapy, 2003
Cost-of-illness studies measure the overall economic impact of a disease on society. Such studies are important in setting public health priorities and for economic evaluation of new treatments. These studies should take the societal perspective and include both direct and indirect costs. Often indirect costs exceed direct costs.
openaire +2 more sources
Cost-of-illness studies measure the overall economic impact of a disease on society. Such studies are important in setting public health priorities and for economic evaluation of new treatments. These studies should take the societal perspective and include both direct and indirect costs. Often indirect costs exceed direct costs.
openaire +2 more sources
Cost-of-Illness in Rare Diseases
2017Cost-of-illness (COI) studies quantify the economic burden of a disease, including direct healthcare and non-healthcare costs and productivity losses. Different approaches can be adopted to evaluate the resources associated to a disease and to calculate the total costs.
Renata, Linertová +2 more
openaire +2 more sources
Cost‐of‐illness of patients with lymphoedema
Journal of the European Academy of Dermatology and Venereology, 2017AbstractBackgroundChronic lymphoedema is characterized by a continuous need for medical treatment, many comorbidities and impaired quality of life. In Germany, about 4.5 million patients are affected by lymphoedema. Thus, lymphoedema causes high direct and indirect costs, even more in case of complications such as erysipelas and ulcers.ObjectiveThe aim
M, Gutknecht +6 more
openaire +2 more sources
Cost of Illness in Adult Patients with Hypopituitarism
PharmacoEconomics, 2000To compare the healthcare costs of patients with hypopituitarism with those of individuals from the general population.A retrospective study of costs over 1 year. Estimates of direct and indirect health-related costs were calculated for patients from the general population using existing databases, and for patients with hypopituitarism using records of
Christer Ehrnborg +5 more
openaire +4 more sources
PharmacoEconomics, 2011
Cost-of-illness (COI) studies aim to assess the economic burden of health problems on the population overall, and they are conducted for an ever widening range of health conditions and geographical settings. While they attract much interest from public health advocates and healthcare policy makers, inconsistencies in the way in which they are conducted
Larg, A., Moss, J.
openaire +3 more sources
Cost-of-illness (COI) studies aim to assess the economic burden of health problems on the population overall, and they are conducted for an ever widening range of health conditions and geographical settings. While they attract much interest from public health advocates and healthcare policy makers, inconsistencies in the way in which they are conducted
Larg, A., Moss, J.
openaire +3 more sources
PharmacoEconomics, 2006
The number of cost-of-illness (COI) studies has expanded considerably over time. One outcome of this growth is that the reported COI estimates are inconsistent across studies, thereby raising concerns over the validity of the estimates and methods.
Ebere, Akobundu +3 more
openaire +2 more sources
The number of cost-of-illness (COI) studies has expanded considerably over time. One outcome of this growth is that the reported COI estimates are inconsistent across studies, thereby raising concerns over the validity of the estimates and methods.
Ebere, Akobundu +3 more
openaire +2 more sources
2020
Cost of illness (COI) or burden of illness (BOI) measures the economic burden of disease and illness on society. They can take either a prevalence- or incidence-based approach. COI or BOI lays the foundation on which the different types of analyses that are used to make decisions in allocation of healthcare resources are framed.
openaire +1 more source
Cost of illness (COI) or burden of illness (BOI) measures the economic burden of disease and illness on society. They can take either a prevalence- or incidence-based approach. COI or BOI lays the foundation on which the different types of analyses that are used to make decisions in allocation of healthcare resources are framed.
openaire +1 more source
PharmacoEconomics, 2009
Cost-of-illness studies determine the total financial burden of a disease by considering direct and indirect costs, including medication, diagnostics and surgery. Studies of resource use and costs associated with primary open-angle glaucoma have used varying methodologies.
Richard G, Fiscella +3 more
openaire +2 more sources
Cost-of-illness studies determine the total financial burden of a disease by considering direct and indirect costs, including medication, diagnostics and surgery. Studies of resource use and costs associated with primary open-angle glaucoma have used varying methodologies.
Richard G, Fiscella +3 more
openaire +2 more sources
Theoretical considerations on the cost of illness
Journal of Health Economics, 1983This paper explores the measurement of the cost of illness from a theoretical perspective. It is shown that under a wide range of circumstances the aggregate willingness to pay ex ante to reduce the probability of an illness exceeds (1) the consumer surplus gained ex post from such a reduction, and also (2) the sum of medical expenditure saved and ...
openaire +2 more sources